ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1664

Autoantibodies Are Associated with Subclinical Atherosclerosis and Cardiovascular Endpoints in Caucasian and African American Women in a Prospective Study:  the Multi-Ethnic Study of Atherosclerosis (MESA)

Darcy S. Majka1, Rowland W. Chang2, Richard M. Pope3, Marius C. Teodorescu4, Elizabeth W. Karlson5, Thanh Huyen T. Vu6, Joseph Kang6 and Kiang Liu7, 1Division of Rheumatology, Northwestern University, Chicago, IL, 2Dept Preventive Med, Northwestern University, Chicago, IL, 3Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL, 4Microbiology, TheraTest Laboratories Inc, Lombard, IL, 5Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL, 7Preventive Medicine, Northwestern University, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis, autoantibodies, coronary artery disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research III: Rheumatic Diseases and Cardiovascular Disease and Risk Assessment

Session Type: Abstract Submissions (ACR)

Background/Purpose: Although the association between rheumatoid arthritis (RA) and cardiovascular disease (CVD) is established, the exact mechanism is not known. Subjects who later develop RA were shown to have increased risk of myocardial infarction (MI) in the preclinical period prior to RA symptoms indicating that autoimmunity might be a risk factor for CVD. Therefore, we tested the hypothesis that RA-related autoantibodies are independent risk factors for subclinical atherosclerosis and subsequent clinical CVD events.

Methods: MESA is a multicenter population based study cohort prospectively collecting CVD outcome and risk factor data in 6814 middle-aged to elderly multi-ethnic participants since 2000. At MESA baseline, rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP-2) by ELISA and coronary artery calcium (CAC) by CT were measured in 6557 AA, Caucasian, Hispanic and Chinese participants who were then followed for 7.1 years for coronary heart disease (CHD) Hard endpoints (MI, resuscitated cardiac arrest, CHD death) and CVD Hard endpoints (MI, cardiac arrest, CHD death, stroke, stroke death). We assessed the associations between baseline RF/anti-CCP and CAC stratified by race/gender using logistic regression adjusting for traditional CVD risk factors. We used Cox regression to determine race/gender-specific associations between RF/anti-CCP and clinical CVD endpoints.

Results: 12.2% had CAC >=300; After 7.1 years, 3.0% had Hard CHD endpoints; 4.8% had Hard CVD endpoints. RF IgM, RF IgA and anti-CCP were positive in 15.9%, 8.7%, and 2.0%, respectively. 4.0% were positive for both and 20.6% were positive for either RF isotype. RA-related autoantibody positivity varied with race and was highest in AA’s (RF: p<0.001, anti-CCP: p<0.003). RF and anti-CCP were associated with CAC in Caucasian and AA women after adjustment for traditional risk factors (Table 1). Table 2 demonstrates strong associations between RA-related autoantibodies and clinical CVD events in AA women. There were no clear associations in Hispanic and Chinese participants.

Table 1.  Adjusted* Odds Ratios (95% CI) of Having Degrees of CAC by Autoantibody Positivity in Caucasian Women and AA Women 

RA-related Autoantibodies

CAC Levels

0

99

CAC>300 vs. CAC=0

Caucasian Women (N=1,323)

RF IgM

2.2 (1.5 – 3.3)

1.4 (0.8 – 2.7)

1.5 (0.8 – 2.8)

RF IgA

1.7 (0.9 – 3.1)

0.9 (0.3 – 2.5)

2.3 (1.0 – 5.5)

Either RF isotypes

2.0 (1.4 – 3.0)

1.2 (0.7 – 2.2)

1.7 (1.0 – 3.1)

Both RF isotypes

2.2 (0.9 – 5.0)

1.5 (0.5 – 4.9)

2.1 (0.7 – 6.7)

CCP

0.9 (0.3 – 2.7)

1.5 (0.5 – 5.3)

0.9 (0.2 – 4.4)

AA Women (N=1000)

RF IgM

1.2 (0.8 – 1.8)

1.4 (0.8 – 2.5)

1.5 (0.8 – 2.8)

RF IgA

1.0 (0.6 – 1.8)        

2.2 (1.1 – 4.2)

2.4 (1.2 – 5.0)

Either RF isotypes

1.2 (0.8 – 1.7)

1.6 (0.9 – 2.7)

1.4 (0.8 – 2.6)

Both RF isotypes

1.1 (0.5 – 2.3)

2.7 (1.1 – 6.3)

4.0 (1.6 – 9.6)

CCP

2.0 (0.9 – 4.8)

1.1 (0.2 – 5.1)

4.0 (1.3 – 12.5)

*Adjusted for age, smoking status, BP, BMI, HDL-c, LDL-c, DM, aspirin use, and cholesterol and BP medication use


Table 2. Adjusted* Hazard Ratios (95% CI) for the Incidence of Clinical Cardiovascular Events over 7.1 Years Follow Up by Autoantibody Positivity 

Caucasian Women

RA-related Autoantibodies

CHD Hard Endpoints (N=31)

CVD Hard Endpoints (N=56)

RF IgM

1.2 (0.4 – 3.0)

1.8 (0.9 – 3.4)

RF IgA

1.1 (0.3 – 4.5)

0.5 (0.1 – 2.2)

Either RF isotypes

1.2 (0.5 – 3.0)

1.6 (0.8 – 3.0)

Both RF isotypes

0.8 (0.1 – 6.1)

0.4 (0.1 – 3.1)

CCP

NA

NA

AA Women

CHD Hard Endpoints (N=19)

CVD Hard Endpoints (N=37)

RF IgM

1.7 (0.7 – 4.5)

2.1 (1.1 – 4.0)

RF IgA

5.0 (1.9 – 12.7)

3.4 (1.7 – 6.9)

Either RF isotypes

2.5 (1.0 – 6.4)

2.7 (1.4 – 5.1)

Both RF isotypes

4.5 (1.6 – 13.0)

3.3 (1.5 – 7.3)

CCP

1.1 (0.1 – 8.3)

2.3 (0.7 – 7.7)

*Adjusted for age, smoking status, BP, BMI, HDL-c, LDL-c, DM, aspirin use, and cholesterol and BP medication use. CHD Hard event outcomes include MI, resuscitated cardiac arrest, and CHD death.  CVD Hard events include MI, cardiac arrest, CHD death, stroke, and stroke death.

Conclusion: This study demonstrates that RA-related autoantibodies are associated with subclinical and clinical atherosclerosis in a population based cohort. These findings indicate autoimmune factors may play a role in the pathogenesis of atherosclerosis, even in individuals without RA.


Disclosure:

D. S. Majka,
None;

R. W. Chang,
None;

R. M. Pope,
None;

M. C. Teodorescu,

TheraTest Laboratories,

1,

TheraTest Laboratories,

3;

E. W. Karlson,
None;

T. H. T. Vu,
None;

J. Kang,
None;

K. Liu,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/autoantibodies-are-associated-with-subclinical-atherosclerosis-and-cardiovascular-endpoints-in-caucasian-and-african-american-women-in-a-prospective-study-the-multi-ethnic-study-of-atherosclero/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology